Multiple Sclerosis Flashcards
Diagnosis indications for CT
head trauma, acute intracranial hemorrhage, tumor/mass, acute/chronic headaches, meningitis, intracranial calcification, fractures, spinal trauma, bone lesions, degenerative spinal disease.
Diagnosis indications for MRI
head trauma, acute/chronic intracranial hemorrhage, tumor/mass, demyelinating disease/lesion, chronic headache, vascular malformations, aneurysm, infection, degenerative spinal disease.
Indications for CT
lower in cost, speed, claustrophobic, obese (>300lbs) pacemaker or metal fragments in heart or eye
Indications for MRI
anatomical detail needed, nonspecific white matter lesions
MRI pros/cons
pros-sensitivity/specificity, no radiation, safe contrast agents, excellent soft tissue resolution, white matter lesions
cons-slow, claustrophobia, strong magnetic field, poor bone detail
MRI reading: T1
lesions mostly dark
dense bone, air and water all dark
fat bright
MRI reading: T2
looks like a negative
CSF, edema, demyelination are bright white
dense bone and air dark
fat, water, and abnormal tissue bright
Neuroanatomy of MS
CNS
UMN- cortical, brainstem, spinal cord
other- cerebellum, other
Prevalence/incidence of MS
young adults
women more than men
20-40 peak onset
Etiology of MS
unknown
environmental- vit D deficiency
Pathogenesis of MS
inflammatory (autoimmune) degenerative disease
acute CNS inflammation-autoimmune response against CNS antigens, T cells cross blood brain barrier, recognize myelin as foreign and attack, this causes demyleination and axonal injury
hallmark sclerotic plaque
end stage of process-areas of myelin and oligodendrocyte loss filled with inflammatory infiltrate
Disease course
insidious, episodic
initial insidious or acute neurologic sign/symptom (sensory, weakness, vision common), then symptoms resolve, then 2nd neurologic insult, then MRI and other diagnostic testing, then diagnosed with MS
5 diseases courses
clinically isolated syndrome (CIS) relapsing-remitting secondary progressive primary progressive progressive-relapsing
clinically isolated syndrome
first event
risk of developing MS